Breast Cancer After Hodgkin Lymphoma: The Price of Success

Curative therapy, including chest RT for Hodgkin lymphoma, is associated with a definitively increased risk of breast cancer, most often manifesting approximately 20 years after treatment. These breast cancers tend to be more aggressive, with greater frequency of hormone receptor negativity and potential HER2 positivity.

Source: CancerNetwork - December 15, 2016 Category: Cancer & Oncology Authors: Frederick Dirbas, MD Melinda L. Telli, MD Veronica Manzo, MD Tags: Breast Cancer Leukemia & Lymphoma Oncology Journal Source Type: news